T cell subsets and cytomegalovirus retinitis in human immunodeficiency virus-infected patients

Journal of Infectious Diseases

Volumn 176, Issue 3, 1997, Pages 790-794

  Tay Kearney, Mei Ling ^a,c   Enger, Cheryl ^a   Semba, Richard D ^a   Royal III, Walter ^a   Dunn, James P ^a   Jabs, Douglas A ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c LIONS EYE INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN;

ADULT; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FLOW CYTOMETRY; HELPER CELL; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RETINITIS; T LYMPHOCYTE SUBPOPULATION;

EID: 0030804010     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517303     Document Type: Article

References (15)

1. Hoover DR, Saah AJ, Bacellar H, et al. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N Engl J Med 1993;329:1922-6.
2. Pertel P, Hirschtick R, Phair J, Chmiel J, Poggensee L, Murphy R. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr 1992;5:1069-74.
3. Reddehase MJ, Mutter W, Munch K, Buhring HJ, Koszinowski UH. CD8-positive T lymphocytes specific for murine cytomegalovirus virus immediate early antigens mediate protective immunity. J Virol 1987;61:3102-8.
4. + T lymphocytes during HIV-1 infection. J Acquir Immune Defic Syndr 1994;7:245-53.
5. Brinchmann JE, Dobloug JH, Heger BH, Haaheim LL, Sannes M, Egeland T. Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations. J Infect Dis 1994;169:730-8.
6. Calvelli T, Denny T, Paxton H, Gelman R, Kagan J. Guidelines for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 1993;14:702-15.
7. Reddehase MJ, Jonjic S, Weiland F, Mutter W, Koszinowski UH. Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors. J Virol 1988;62:1061-5.
8. + in late opportunistic infections of patients with AIDS. Res Immunol 1992;143:903-7.
9. + T lymphocytes and cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 1995;120:283-90.
10. Schrier RD, Freeman WR, Wiley CA, McCutchan JA, HNRC group. Immune predispositions for cytomegalovirus retinitis in AIDS. J Clin Invest 1995;95:1741-6.
11. Heagy W, Crumpacker C, Lopez PA, Finberg RW. Inhibition of immune functions by antiviral drugs. J Clin Invest 1991;87:1916-24.
12. Ybarrondo B, O'Rourke AM, Brian AA, Mescher MF. Contribution of lymphocyte function-associated-1/intercellular adhesion molecule-l binding to the adhesion/signalling cascade of cytotoxic T lymphocyte activation. J Exp Med 1994;179:359-63.
13. Welsh RM, Brubaker JO, Vegas-Cortes M, O'Donnell CL. Natural killer (NK) cell response to virus infections in mice with severe immunodeficiency. The stimulation of NK cells and NK-dependent control of virus infection occur independently of T and B cell function. J Exp Med 1991;173:1053-63.
14. Miles SA, Mitsuyasu RT, Moreno J, et al. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. Blood 1991;77:2109-77.
15. Riddell SR, Greenburg PD. Principles for adoptive T cell therapy of human viral diseases. Annu Rev Immunol 1995;13:545-86.